Attention Deficit Hyperactivity Disorder and methylphenidate: When society misunderstands medicine

McGill Journal of Medicine

Volumn 3, Issue 2, 1997, Pages 105-114

  Kaminester, David D ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF CHICAGO   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CHLORPROMAZINE; CLONIDINE; DEXAMPHETAMINE; HALOPERIDOL; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANOREXIA; ATTENTION DEFICIT DISORDER; BRAIN METABOLISM; CLINICAL FEATURE; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; REVIEW; SOMNOLENCE; TACHYCARDIA; TREATMENT INDICATION; TREATMENT OUTCOME; VERTIGO;

EID: 0031399581     PISSN: 1201026X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Barkley, RA. Attention Deficit Hyperactivity Disorder: A Handbook of Diagnosis & Treatment. New York: The Guilford Press; 1996: 3-38, 573-612.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC: American Psychiatric Association; 1994: 78-85.
3. Hoekelman, RA et al., eds. Pediatric Primary Care. St. Louis: Mosby-Year Book; 1992: 627-30.
4. Safer DJ, Zito JM, Fine EM. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 98(6): 1084-1088; 1996.
5. Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. Raven Press Ltd.: New York; 1995: 1643-52.
6. Levy F, Hay D, McLaughlin M, et al. Twin-sibiling differences in parental reports of ADHD, speech, reading, and behavioral problems. Journal of Child Psychology and Psychiatry and Allied Disciplines 37(5): 569-578; 1996.
7. Sherman DK, McGue MK, Ianoco WG. Twin concordance for attention deficit hyperactivity disorder: a comparison of teachers' and mothers' reports. The American Journal of Psychiatry 154(4): 532-535; 1997.
8. Biederman J, Milberger S, Faraone SV, et al. Family environment risk factors for attention deficit hyperactivity disorder: a test of Rutter's indicators of adversity. Archives of General Psychiatry 52(6): 464-470; 1995.
9. Kandel ER, Schwartz JH, Jessell TM, eds. Principles of Neural Science, 3rd edition. Norwalk: Appleton & Lange; 1991: 823-838.
10. Mateer CA, Williams D. Effects of frontal lobe injury in childhood. Developmental Neuropsychology 7: 359-376; 1991.
11. Welsh MC, Pennington BF. Assessing frontal lobe functioning in children: views from developmental psychology. Developmental Neuropsychology 4: 199-230; 1988.
12. Malone, MA, Kershner, JR, Swanson, JM. Hemispheric processing and methylphenidate effects in attention-deficit hyperactivity disorder. Journal of Child Neurology 9(2): 181-189; 1994.
13. Hynd GW, Semrud-Clikeman M, Lorys AR, et al. Brain morphology in developmental dyslexia and attention deficit disorder/hyperactivity. Archives of Neurology 47(8): 919-926; 1990.
14. Giedd JN, Castellanos FX, Casey BJ, et al. Quantitative morphology of the corpus callosum in attention deficit hyperactivity disorder. The American Journal of Psychiatry 151(5): 665-669; 1994.
15. Semrud-Clikeman M, Filipek PA, Biederman J, et al. Attention deficit hyperactivity disorder: magnetic resonance imaging morphometric analysis of the corpus callosum. Journal of the American Academy of Child and Adolescent Psychiatry 33(6): 875-881; 1994.
16. Castellanos FX, Giedd JN, Eckberg P, et al. Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder. The American Journal of Psychiatry 151(12): 1791-1796; 1994.
17. Castellanos FX, Giedd JN, Marsh WL, et al. Quantitative brain magnetic resonance imaging in attention deficit hyperactivity disorder. Archives of General Psychiatry 53(7): 607-616; 1996.
18. Lou HC, Henriksen L, Bruhn P. Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Archives of Neurology 41(8): 825-9; 1984.
19. Lou HC, Henriksen L, Bruhn P, et al. Striatal dysfunction in attention deficit and hyper-kinetic disorder. Archives of Neurology 46(1): 48-52; 1989.
20. Zametkin AJ, Nordahl TE, Gross M, et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. The New England Journal of Medicine 323(20): 1361-6; 1990.
21. Zametkin AJ, Liebenauer LL, Fitzgerald GA, et al. Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Archives of General Psychiatry 50(5): 333-340; 1993.
22. Ernst M, Liebenauer LL, King C, et al. Reduced brain metabolism in hyperactive girls. Journal of the American Academy of Child and Adolescent Psychiatry 33(6): 858-868; 1994.
23. Ross RG, Hommer D, Breiger D, et al. Eye movement task related to frontal lobe functioning in children with attention deficit disorder. Journal of the American Academy of Child and Adolescent Psychiatry 33(6): 869-874; 1994.
24. Hauser P, Zametkin AJ, Martinez P, et al. Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. The New England Journal of Medicine 328(4): 997-1001; 1993.
25. Rovet J, Alvarez M. Thyroid hormone and attention in congenital hypothyroidism. Journal of Pediatric Endocrinology and Metabolism 9(1): 63-66; 1996.
26. Rovet J, Alvarez M. Thyroid hormone and attention in school-age children with congenital hypothyroidism. Journal of Child Psychology and Psychiatry 37(5): 579-85; 1996.
27. Alvarez M, Guell R, Chong D, et al. Attentional processing in hyperthyroid children before and after treatment. Journal of Pediatric Endocrinology & Metabolism 9(4): 447-454; 1996.
28. Matochik JA, Zametkin, AJ, Cohen RM, et al. Abnormalities in sustained attention and anterior cingulate metabolism in subjects with resistance to thyroid hormone. Brain Research 723(1-2): 23-28; 1996.
29. Weiss G, Minde K, Douglas V, et al. Comparison of the effects of chlorpromazine, dextroamphetamine, and methylphenidate on the behavior and intellectual functioning of hyperactive children. Canadian Medical Association Journal 104(1): 20-25; 1971.
30. Kaplan HI, Sadock BJ, Grebb JA. Kaplan and Sadock's Synopsis of Psychiatry. 7th edition. Baltimore: Williams & Wilkins; 1994: 1063-8.
31. Levy F, Hobbes G. The action of stimulant medication in attention deficit disorder with hyperactivity: dopaminergic, noradrenergic, or both? Journal of the American Academy of Child and Adolescent Psychiatry 27(6): 802-805; 1988.
32. Matochik JA, Nordahl TE, Gross M, et al. Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity. Neuropsychopharmacology 8(4): 377-386; 1993.
33. Matochik JA, Liebenauer LL, King C, et al. Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment. The American Journal of Psychiatry 151(5): 658-664; 1994.
34. Ernst M, Zametkin AJ, Matochik JA, et al. Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD). Preliminary findings. Psychopharmacology Bulletin 30(2): 219-225; 1994.
35. Barkley, R. The Merrow report: a dubious documentary. The ADHD Report 3(6): 1-4; 1995.
36. Baren, M. The case for ritalin: a fresh look at the controversy. Contemporary Pediatrics 6: 16-28; 1989.
37. Safer DJ, Krager JM. Effect of a media blitz and a threatened lawsuit on stimulant treatment. JAMA 268(8): 1004-7; 1992.
38. Kwasman A, Tinsley BJ, Lepper HS. Pediatricians' knowledge and attitudes concerning diagnosis and treatment of attention deficit and hyperactivity disorders: a national survey approach. Archives of Pediatric and Adolescent Medicine 149(11); 1211-16; 1995.
39. Klein RG, Mannuzza S. Long-term outcome of hyperactive children: a review. Journal of the American Academy of Child and Adolescent Psychiatry 30(3): 383-7; 1991.
40. Barkley RA, Fischer M, Edelbrock CS et al. The adolescent outcome of hyperactive children diagnosed by research criteria: I.An 8-year prospective follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry 29(4): 546-557; 1990.
41. Mannuzza S, Klein RG, Bessler A et al Adult outcome of hyperactive boys. Archives of General Psychiatry 50(7): 565-576; 1993.
42. Safer DJ, Allen RP. Stimulant drug treatment of hyperactive adolescents. Diseases of the Nervous System 36(8): 454-7; 1975.
43. DuPaul GJ, Rapport MD. Does methylphenidate normalize the classroom performance of children with attention deficit hyperactivity disorder? Journal of the American Academy of Child and Adolescent Psychiatry 32(1): 190-8; 1993.
44. Rapport MD, Denney C, DuPaul GJ, et al. Attention deficit disorder and methylphenidate: normalizaton rates, clinical effectiveness, and response prediction in 76 children. Journal of the American Academy of Child and Adolescent Psychiatry 33(6): 882-93; 1994.
45. Weiss G, Kruger E, Danielson U, et al. Effect of long-term treatment of hyperactive children with methylphenidate. Canadian Medical Association Journal 112(2): 159-165; 1975.
46. Hechtman L, Weiss G, Perlman T. Young adult outcome of hyperactive chidren who received long-term stimulant treatment. Journal of the American Academy of Child Psychiatry 23(3): 261-9; 1984.
47. Gadow KD, Sverd J, Sprafkin J, et al. Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. Archives of General Psychiatry 52(6): 444-55; 1995.
48. Ahmann PA, Waltonen SJ, Olson KA, et al. Placebo-controlled evaluation of ritalin side effects. Pediatrics 91(6): 1101-6; 1993.
49. Gross-Tsur V, Manor O, Van der Meere J, et al. Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective? The Journal of Pediatrics 130(1): 40-44; 1997.
50. Funk JB, Chessare JB, Weaver MT, et al. Attention deficit hyperactivity disorder, creativity, and the effects of methylphenidate. Pediatrics 91(4): 816-9; 1993.
51. Solanto M, Wender E. Does methylphenidate constrict cognitive functioning? Journal of the American Academy of Child and Adolescent Psychiatry 28(6): 897-902; 1989.
52. Mattes JA, Gittelman R. Growth of hyperactive children on maintenance regimen of methylphenidate. Archives of General Psychiatry 40(3): 317-321; 1983.
53. Klein RG, Mannuzza S. Hyperactive boys almost grown up: III. Methylphenidate effects on ultimate height. Archives of General Psychiatry 45(12): 1131-4; 1988.
54. DuPaul GJ, Barkley RA, McMurray MB. Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. Journal of the American Academy of Child and Adolescent Psychiatry 33(6): 894-903; 1994.
55. Buitelaar JK, Van der Gaag RJ, Swaab-Barneveld H, et al. Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 34(8): 1025-32; 1995.
56. Frank Y. Visual event related potentials after methylphenidate and sodium valproate in children with attention deficit hyperactivity disorder. Clinical Electroencephalography 24(1): 19-24; 1993.
57. Young ES, Perros P, Price GW, et al. Acute challenge ERP as a prognostic of stimulant therapy outcome in attention-deficit hyperactivity disorder. Biological Psychiatry 37(1): 25-33;1995.
58. Rapoport JL, Quinn PO, Bradbard G, et al. Imipramine and methylphenidate treatments of hyperactive boys. Archives of General Psychiatry 30(6): 789-793; 1974.
59. Quinn PO, Rapoport JL. One-year follow-up of hyperactive boys treated with imipramine or methylphenidate. The American Journal of Psychiatry 132(3): 241-245; 1975.
60. Werry JS, Aman MG, Diamond E. Imipramine and methylphenidate in hyperactive children. Journal of Child Psychology and Psychiatry and Allied Disciplines 21(1):27-35; 1980.
61. Garfinkel BD, Wender P, Sloman L, et al. Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children. Journal of the American Academy of Child Psychiatry 22(4): 343-8; 1983.
62. Zametkin A, Rapoport JL, Murphy DL, et al. Treatment of hyperactive children with monoamine oxidase inhibitors. Archives of General Psychiatry 42(10): 962-6; 1985.
63. Hunt RD, Minderaa RB, Cohen DJ. The therapeutic effect of clonidine in attention deficit disorder with hyperactivity: a comparison with placebo and methylphenidate. Psychopharmacology Bulletin 22(1): 229-36; 1986.
64. Simeon JG, Ferguson HB, Van Wyck Fleet J. Bupropion effects in attention deficit and conduct disorders. Canadian Journal of Psychiatry 31(6): 581-5; 1986.
65. Barrickman LL, Perry PJ, Allen AJ, et al. Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 34(5): 649-57; 1995.
66. Rapoport JL, Zametkin A, Donnelly M, et al. New drug trials in attention deficit disorder. Psychopharmacology Bulletin 21(2):232-6; 1985.
67. Pelham WE, Carlson C, Sams SE, et al. Separate and combined effects of methylphenidate and behavior modification on boys with attention deficit-hyperactivity disorder in the classroom. Journal of Consulting and Clinical Psychology 61(3): 506-15; 1993.
68. Ajibola O, Clement PW. Differential effects of methylphenidate and self-reinforcement on attention-deficit hyperactivity disorder. Behavior Modification 19(2): 211-33; 1995.